About Index Trending news
Lists
Pricing
ApoGen Biotechnologies

ApoGen Biotechnologies

ApoGen Biotechnologies

As the arsenal of available cancer therapies has grown and evolved from cytotoxic chemotherapy to targeted therapy to immunotherapy, one fact has unfortunately remained constantnearly all cancer drug therapies eventually fail due to the development of dru

Elsewhere

Alexa global traffic share

Latest funding
Venture capital (Series A)
$7,000,000
Employees

Team size

2
Locations
HQ
$7,000,000 Venture capital (Series A)
FinSMEs , Xconomy , businesswire , +1

ApoGen Biotechnologies Raises $7M in Series A Funding